Pediatric News - Aciphex
Friday, December 26th, 2008 Aciphex (rabeprazole sodium, Eisai Corporation)
The Food and Drug Administration approved an adolescent indication for Aciphex (rabeprazole sodium) 20 mg for short-term treatment of gastroesophageal reflux disease in patients 12 years and older.
* Recommended Dosage: A 20-mg oral dose daily for up to 8 weeks is recommended for adolescents aged 12 years and over. The tablets can be …
